Table 5.
Short–term oncologic outcomes for included randomized controlled trials trials
| Study | Arm | N | N Mortality (%) | N Morbidity (%) | N Anastomotic Leak (%) | N Intraabdominal Abscess (%) | N sSSI (%) | N Sepsis (%) | N Ileus (%) | Mean LOS, d (SD) |
|---|---|---|---|---|---|---|---|---|---|---|
| [4] | Surgery | 63 | 7 (11.1) | 42 (66.7) | 0 | 14 (22.2) | – | 7 (11.1) | – | 35 (13–73) |
| Stoma | 58 | 7 (12.1) | 31 (53.4) | 2 (3.4) | 3 (5.2) | – | 6 (10.3) | – | 49 (10–223) | |
| [27] | Surgery | 24 | 0 | 17 (70.8) | 2 (8.3) | 1 (4.2) | 8 (33.3) | 1 (4.2) | 0 | 14 (7–55) |
| Stent | 24 | 0 | 2 (8.3) | 0 | 0 | 2 (8.3) | 0 | 0 | 13.5 (7–29) | |
| [29] | Surgery | 13 | 1 (7.7) | 7 (53.8) | 4 (30.8) | 0 | 2 (15.4) | – | 2 (15.4) | 10 (5–15)* |
| Stent | 15 | 0 | 2 (13.3) | 0 | 0 | 2 (13.3) | – | 0 | 13 (10–16)* | |
| [9] | Surgery | 30 | 1 (3.3) | 17 (56.7) | 2 (6.7) | 0 | – | – | – | 17 (7–126)* |
| Stent | 30 | 3 (10.0) | 15 (50.0) | 2 (6.7) | 1 (3.3) | – | – | – | 23 (9–67)* | |
| [28] | Surgery | 51 | 5 (9.8) | 23 (45.1) | 1 (2.0) | 4 (7.8) | 4 (7.8) | 3 (5.9) | 2 (3.9) | – |
| Stent | 47 | 5 (10.6) | 25 (53.2) | 5 (10.6) | 4 (8.5) | 3 (6.4) | 0 | 9 | – | |
| [67] | Surgery | 19 | 3 (15.9) | 11 (57.9) | 0 | 0 | 4 (21.1) | – | – | 13 (7–41)* |
| Stent | 20 | 0 | 7 (35.0) | 1 (5.0) | 1 (5.0) | 3 (15.0) | – | – | 14 (7–41)* | |
| [13] | Surgery | 30 | – | – | 1 (3.3) | – | 9 (30.0) | 8 | ||
| Stent | 30 | – | – | 0 | – | 3 (10.0) | 13 | |||
| [11]† | Surgery | 24 | – | – | – | – | – | – | – | – |
| Stent | 24 | – | – | – | – | – | – | – | – | |
| [14] | Surgery | 46 | – | 9 (19.6) | – | – | – | – | – | 10.92 (6.85) |
| Stoma | 28 | – | 3 (10.7) | – | – | – | – | – | ||
| [46]§ | Surgery | 32 | – | – | – | – | – | – | – | – |
| Stent | 26 | – | – | – | – | – | – | – | – | |
| [7]‡ | Surgery | 59 | 3 (5.1) | 34 (57.6) | 2 (3.4) | 0 | 7 (12.5) | 3 (5.1) | 2 (3.4) | 11 (8–15) |
| Stent | 56 | 4 (7.1) | 29 (51.8) | 3 (5.4) | 1 (1.8) | 4 (7.1) | 4 (7.1) | 2 (3.6) | 15 (12–20) | |
| [12]‡ | Surgery | 59 | – | – | – | – | – | – | – | – |
| Stent | 56 | 50.0 | – | – | – | – | – | – | – |
N number of patients, sSSI superficial surgical site infection, LOS length of stay, d day(s))
† = same study population; ‡ = same study population; § = same study population